Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gainsharing Should Be Limited To Case-By-Case Approvals – OIG’s Morris

This article was originally published in The Gray Sheet

Executive Summary

Prospective gainsharing programs should continue to be evaluated on a case-by-case basis to ensure that the practice is implemented constructively and at minimal risk to beneficiaries, according to HHS Office of Inspector General Chief Counsel Lewis Morris

You may also be interested in...



Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill

The House and Senate passed a deficit reduction bill that would authorize a gainsharing demonstration program at up to six sites beginning in 2007

Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill

The House and Senate passed a deficit reduction bill that would authorize a gainsharing demonstration program at up to six sites beginning in 2007

Johnson’s Draft Gainsharing Bill Provides Some Safeguards For Devices

Hospitals would need to make "therapeutic equivalent medical products" that are excluded from gainsharing programs available for physicians to use, under a draft bill being circulated by Rep. Nancy Johnson (R-Conn.)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel